And the USA is missing out.
I jumped in on cell tech more than 10 years ago. At that time, USA was in the forefront of the tech. Lost my ass on companies set up in USA. FDA and politics killed those companies.
I would not invest again for companies based in the USA. Waited for an offshore company to appear as a possible forerunner. GSCG is that baby.
Lots of 'seemingly reputable' companies have cropped up overseas as well but either too pricey for my taste or they too seem to wallow at a low level of return. I continued to wait.
As I see it, the LAHO/GSCG RM has all the ingredients I seek. Cutting edge, financially set and a business plan that is dynamic for guaranteeing continued growth.
Forces here in the USA are still intent on keeping dynamic foreign cell tech companies at bay. However, the crack is emerging.
Americans want what cell tech has to offer...even if they have to travel overseas to get it. GSCG fulfills that need. It is, from my perspective, inevitable that GSCG is a game changer. It WILL trade its shares on the OTC trade platform. Get ready!!
Share pricing set through the LAHO RM are a godsend. Wait a year and be amazed how you got in at a time when shares were affordable.
